Concepedia

Lukas Kraehenbuehl

LK

Statistics

Publications

11

Citations

617

H-Index

11

Active since

2021

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Swim Across America

Parker Institute for Cancer Immunotherapy

University Hospital of Zurich

Cornell University

Lukas Kraehenbuehl is an author at Memorial Sloan Kettering Cancer Center specializing in oncology, immunotherapy, and cancer immunotherapy.

ORCID

Publications per year

2021–2025

11

Publications

11

T cell immunotherapies engage neutrophils to eliminate tumor antigen escape variants

Daniel Hirschhorn, Sadna Budhu, Lukas Kraehenbuehl et al. · Cell · 2023 · 296 citations · Full text

, , +14

European recommendations for management of immune checkpoint inhibitors‐derived dermatologic adverse events. The EADV task force ‘Dermatology for cancer patients’ position statement

Zoé Apalla, Vasiliki Nikolaou, Davide Fattore et al. · Journal of the European Academy of Dermatology and Venereology · 2021 · 99 citations · Full text

, , +17

In vivo tumor immune microenvironment phenotypes correlate with inflammation and vasculature to predict immunotherapy response

Aditi Sahu, Lukas Kraehenbuehl, Candice Byers et al. · Nature Communications · 2022 · 55 citations · Full text

, , +17

Management of immune-related cutaneous adverse events with dupilumab

Alyce Mei-Shiuan Kuo, Stephanie Gu, Joseph R. Stoll et al. · Journal for ImmunoTherapy of Cancer · 2023 · 49 citations · Full text

, , +17

Immunologic Profiling of Immune-Related Cutaneous Adverse Events with Checkpoint Inhibitors Reveals Polarized Actionable Pathways

Mario E. Lacouture, Elena Goleva, Neil J. Shah et al. · Clinical Cancer Research · 2024 · 31 citations · Full text

, , +17

1–5 of 11